Jump Financial LLC Purchases 3,751 Shares of DaVita Inc. $DVA

Key Points

• Jump Financial LLC increased its stock holdings in DaVita Inc. by 77.4% in Q1, now owning 8,600 shares valued at approximately $1.32 million.
• DaVita reported an earnings per share of $2.95 for its last quarter, exceeding analysts' estimates of $2.70, along with a revenue of $3.38 billion.
• The consensus target price for DaVita's stock has been set at $164.00, with varying ratings from analysts, including some upgrades to "buy".

Jump Financial LLC raised its stake in DaVita Inc. (NYSE:DVA - Free Report) by 77.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,600 shares of the company's stock after acquiring an additional 3,751 shares during the period. Jump Financial LLC's holdings in DaVita were worth $1,316,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in DVA. Iron Triangle Partners LP acquired a new position in DaVita in the 4th quarter valued at $38,946,000. GAMMA Investing LLC raised its holdings in shares of DaVita by 14,695.8% during the 1st quarter. GAMMA Investing LLC now owns 234,809 shares of the company's stock worth $35,919,000 after buying an additional 233,222 shares in the last quarter. Northern Trust Corp raised its holdings in shares of DaVita by 20.2% during the 1st quarter. Northern Trust Corp now owns 890,632 shares of the company's stock worth $136,240,000 after buying an additional 149,858 shares in the last quarter. Nuveen LLC acquired a new position in shares of DaVita during the 1st quarter worth $20,218,000. Finally, Rovin Capital UT ADV acquired a new position in shares of DaVita during the 1st quarter worth $18,442,000. 90.12% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, insider James O. Hearty sold 2,351 shares of the company's stock in a transaction that occurred on Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total value of $352,650.00. Following the completion of the transaction, the insider directly owned 26,038 shares of the company's stock, valued at $3,905,700. This represents a 8.28% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 1.50% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of equities analysts have recently commented on the company. Truist Financial set a $148.00 price target on DaVita in a report on Friday, August 8th. Wall Street Zen raised DaVita from a "hold" rating to a "buy" rating in a report on Friday, August 22nd. Finally, Barclays lowered their price target on DaVita from $169.00 to $160.00 and set an "equal weight" rating for the company in a report on Thursday, August 7th. Three investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $164.00.

DaVita Stock Down 1.2%

DVA stock traded down $1.66 during trading on Tuesday, reaching $136.11. 357,667 shares of the stock were exchanged, compared to its average volume of 853,153. The firm's 50 day moving average is $139.76 and its 200 day moving average is $142.29. DaVita Inc. has a twelve month low of $126.07 and a twelve month high of $179.60. The company has a current ratio of 1.39, a quick ratio of 1.34 and a debt-to-equity ratio of 23.18. The firm has a market cap of $9.73 billion, a P/E ratio of 13.37, a price-to-earnings-growth ratio of 0.99 and a beta of 1.13.

DaVita (NYSE:DVA - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $2.95 earnings per share for the quarter, topping analysts' consensus estimates of $2.70 by $0.25. The business had revenue of $3.38 billion for the quarter, compared to the consensus estimate of $3.36 billion. DaVita had a return on equity of 369.39% and a net margin of 6.35%.The firm's revenue for the quarter was up 6.1% on a year-over-year basis. During the same period in the prior year, the business earned $2.00 EPS. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. As a group, research analysts forecast that DaVita Inc. will post 10.76 EPS for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.